ANTONIO JOSÉ
TORRES GARCÍA
Catedrático de universidad
Hospital Universitario Príncipe de Asturias
Alcalá de Henares, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (11)
2023
-
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945
2021
-
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic
Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749
-
The SARS-CoV-2 first wave impact in the acute inflammatory surgical pathologies
Scientific Reports, Vol. 11, Núm. 1
2014
-
Relationship of immunohistochemical biomarker expression and lymph node involvement in patients undergoing surgical treatment of NSCLC with long-term follow-up
Tumor Biology, Vol. 35, Núm. 5, pp. 4551-4559
2012
-
Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition
Oncology, Vol. 82, Núm. 3, pp. 153-164
2003
-
Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer
International Journal of Cancer, Vol. 107, Núm. 5, pp. 781-790
1997
-
Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: Rationale of sequential processing of frozen and paraffin-embedded tissue
World Journal of Surgery, Vol. 21, Núm. 3, pp. 323-329
1995
-
Concordance between serum and cytosolic levels of CEA CA125 and SCC antigens in patients with non-small cell lung cancer
Anticancer Research, Vol. 15, Núm. 6 B, pp. 2811-2817
1994
-
Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non‐small cell lung cancer
Cancer, Vol. 73, Núm. 9, pp. 2305-2311